TYENNE

TOCILIZUMAB-AAZG · Fresenius Kabi USA, LLC

Drug timelines are a Plus or Pro feature.

12 regulatory and trial events tracked for TYENNE, covering 2024-03-05 to 2026-08-19. Get the full timeline:

Most recent: EMA Authorised: Tyenne (tocilizumab) — Fresenius Kabi Deutschland GmbH